Researchers from the Mayo Clinic (USA) have identified a novel genetic association with resistance to entorhinal cortex (ERC) tau deposition in older adults . Their study results, intended for the cancelled AAN 2020 conference, also suggest that tau deposition may have a genetic architecture distinct from known Alzheimer's disease (AD) risk genes.
The heritable influences pertaining to the susceptibility and resistance to tau deposition are not fully understood yet. The objective was to identify genetic factors associated with tau deposition in older adults. The recent availability of tau-PET allows for testing possible associations between common genetic variants and tau burden of the ERC, which is a sensitive marker of early tau deposition.
Included were 754 individuals >50 years from the Mayo Clinic Study of Aging (established in 2004) with genome-wide genotype and regional tau-PET (AV-1451) data. The mean age was 72.4 years, 54.6% were male, ...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Long-term safety of ND0612 in idiopathic Parkinson’s disease Next Article
Sustained seizure reductions with cannabidiol for Lennox-Gastaut Syndrome »
Table of Contents: EAN 2020
Headache and Pain
Neuromyelitis Optica Spectrum Disorder
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.